Pursuant to Regulation 33 of SEBI(LODR), 2015, we are pleased to submit the Financial Results for the Qaurter and Half Year ended 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.3 pts more than its Edible Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Natraj Proteins reported unaudited results for Q2 FY26 with revenue from operations of Rs. 2,692.17 lakhs, up about 18% from Rs. 2,278.62 lakhs in Q2 FY25. However, for the half-year (H1 FY26), revenue declined to Rs. 5,347.91 lakhs from Rs. 6,131.76 lakhs in H1 FY25, a drop of nearly 13%. The company continued to post losses, with a Q2 loss of Rs. 164.98 lakhs (vs Rs. 101.45 lakhs loss in Q2 FY25) and an H1 loss of Rs. 286.46 lakhs (vs Rs. 275.69 lakhs loss). Operating cash flow remained positive at Rs. 159.40 lakhs for H1, though sharply lower than the full-year FY25 figure. The statutory auditor (Bhutoria Ganesan & Co) issued a clean limited review report with no qualifications.
Weak set of numbers for shareholders — top-line is shrinking on a half-yearly basis and losses are widening quarter-on-quarter, signalling continued stress in the core solvent extraction and commodities trading business despite the small sequential improvement in Q2 revenue. Near-term sentiment is likely to remain negative.